Abby E. Pelletier
FDA Investigator
- Abby E. Pelletier first started conducting FDA inspections in 2008, with the last inspection in 2018. Over that time, Abby E. Pelletier has conducted 178 inspections at 142 companies across 155 sites.
Get Abby Pelletier's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Intas Pharmaceuticals Limited, Ahmedabad | 2018
Out of stock
FDA 483 TeleMed Systems, Inc., Hudson | 2018
Out of stock
FDA 483 EBI Patient Care, Inc., Guaynabo | 2018
Out of stock
FDA 483 NCS Pearson, Boston | 2017
Out of stock
FDA 483 Seabrook Medical, LLC, Seabrook | 2017
Out of stock
FDA 483 TransMedics, Inc., Andover | 2017
Out of stock
FDA 483 TESco Associates, Inc., Tyngsboro | 2016
Out of stock
Co-Investigators (31)
- Matthew B. Casale, FDA Investigator
- Laiza V. Garcia, FDA Investigator
- Nydia E. Colon, FDA Investigator
- Concepcion Cruz, FDA Investigator
- Nabil Nakhoul, FDA Investigator
- Stephen C. Smith, FDA Investigator
- Sherry K. Markwell, FDA Investigator
- Pamela L. Ogonowski, FDA Investigator
- Stacey S. Degarmo, FDA Investigator
- Douglas S. Joslin, FDA Investigator
- Matthew D. Silverman, FDA Investigator
- Joseph T. Frost, FDA Investigator
- James W. Whitney, FDA Investigator
- Philip H. Lafleur, FDA Investigator
- Camerson E. Moore, FDA Investigator
- Susanne M. Richardson, FDA Investigator
- Elizabeth B. Griffin, FDA Investigator
- Douglas Fiorentino, FDA Investigator
- Maura Rooney, FDA Investigator
- Allison A. Rodriguez, FDA Investigator
- Mark E. Farrell, FDA Investigator
- Tamara S. Rosbury, FDA Investigator
- Amy C. Jordan, FDA Investigator
- Paul P. Geraci, FDA Investigator
- Michael P. Sweeney, FDA Investigator
- Lauren M. Lawrance, FDA Investigator
- Ellen P. Madigan, FDA Investigator
- Richard F. Hapke, FDA Investigator
- Robert J. Martin, FDA Investigator
- Margaret E. Walsh, FDA Investigator
- Michael J. Pasternak, FDA Investigator